
Camxone-T 1.125gm Injection
Marketer
Chemross Lifesciences
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Camxone-T 1.125gm Injection
Triclox 1.125g injection is a multi-component medication used to combat diverse bacterial infections. Its action inhibits microbial proliferation, thereby limiting infection spread. Administration must always be overseen by a qualified medical practitioner. Strict adherence to the prescribed dosage schedule is crucial; premature cessation can compromise treatment efficacy. Complete the full course, regardless of symptom improvement. Typical side effects may include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening symptoms to your physician immediately. Seek urgent medical attention for allergic reactions such as rashes, pruritus, edema, or dyspnea. Inform your doctor of all current medications before commencing treatment. Consult your doctor before use if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if experiencing somnolence or dizziness. Adequate rest, a nutritious diet, and sufficient hydration will aid recovery. Your doctor may order blood tests and other investigations to monitor your response to the medication.
Uses of Camxone-T 1.125gm Injection
Infections caused by bacteria
Major Benefits of Camxone-T 1.125gm Injection:
This medication will be administered by your physician or their qualified nurse; self-medication is strongly discouraged.
Common Side effects of Camxone-T 1.125gm Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Camxone-T 1.125gm Injection:
This medication will be administered by your physician or their nursing staff; self-medication is strictly prohibited.
How Camxone-T 1.125gm Injection works:
Ceftriaxone and Tazobactum, combined as Camxone-T 1.125gm Injection, offer a powerful antibacterial approach. Ceftriaxone, a crucial antibiotic component, disrupts bacterial cell wall synthesis, hindering their ability to thrive. The beta-lactamase inhibitor, Tazobactum, counteracts bacterial resistance mechanisms, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Camxone-T 1.125gm Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Camxone-T (1.125 gm) is usually deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harm to fetuses; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Camxone-T 1.125gm Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Camxone-T 1.125gm Injection might induce drowsiness, visual disturbances, or dizziness. Refrain from operating vehicles should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Camxone-T 1.125gm Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Administering Camxone-T 1.125gm Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Altering the Camxone-T 1.125gm Injection dosage is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Camxone-T 1.125gm Injection :
Omitting a scheduled dose of Camxone-T 1.125gm Injection necessitates contacting your physician.
Facts to Know About Camxone-T 1.125gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
